Michele L. R. Heffernan

Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia

Michele L. R. Heffernan, Lee W. Herman, Scott P. Brown et al. · ACS Medicinal Chemistry Letters · 2021 · 70 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Effects of D‐amino acid oxidase inhibition on memory performance and long‐term potentiation in vivo

Seth C. Hopkins, Una C. Campbell, Michele L. R. Heffernan et al. · Pharmacology Research & Perspectives · 2013 · 36 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Structural, Kinetic, and Pharmacodynamic Mechanisms of <scp>d</scp>-Amino Acid Oxidase Inhibition by Small Molecules

Seth C. Hopkins, Michele L. R. Heffernan, Lakshmi D. Saraswat et al. · Journal of Medicinal Chemistry · 2013 · 35 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Novel human<scp>D</scp>-amino acid oxidase inhibitors stabilize an active-site lid-open conformation

Ryan T. Terry-Lorenzo, Lawrence Chun, Scott P. Brown et al. · Bioscience Reports · 2014 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Pharmacodynamic Effects of a d-Amino Acid Oxidase Inhibitor Indicate a Spinal Site of Action in Rat Models of Neuropathic Pain

Seth C. Hopkins, Fei‐Yue Zhao, Carrie A. Bowen et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 23 citations

Medicine, Neuroscience, Pharmacology +17